S.horowits_Logo

News & Insightse

Filter by

Or

Updates

Update to Procedure No. 6 of the Ministry of Health – A Breakthrough in Pharmacovigilance Policy?

The Department of Risk Management and Medicinal Information at the Israeli Ministry of Health has published, for the public comments, a draft update to procedure No. 6, titled “Reporting of Adverse Events and New Safety Information”.
Read

Updates

Limit Your Expectations to Get Around the Statute of Limitation

A dispute between two pharmaceutical manufacturers gave rise to an important ruling by the Supreme Court on key issues with respect to Israeli statute of limitation (C.A, 5474/18 Unipharm Ltd. v. Glaxo SmitkKline p.l.c (18.6.2024).
Read

Articles

The revolution in the Israeli Patent Law was confirmed, once again, by the Supreme Court?

The Israeli Supreme Court’s decision in Sanofi v. Unipharm (December 26, 2023) marks a key development in patent law and the Unjust Enrichment Law. 
Read

Articles

Novartis’ PI Motion re Gilenya® Denied: Generic Entry Does Not Necessarily Cause “Catastrophic Damages” to the Brand

The Israeli Tax Authority has issued groundbreaking guidance on SAFE instruments, providing much-needed clarity for venture capital investments.
Read

Subscribe

Get the latest updates straight to your inbox